Bristol-Myers Squibb supplies Breyanzi CAR POS T-Cells to Clatterbridge
- The Clatterbridge Cancer Centre NHS Foundation Trust
- North West
- Direct award
- 8 October 2026 to 9 October 2026
The Clatterbridge Cancer Centre NHS Foundation Trust bought Breyanzi CAR POS T-Cells from Bristol-Myers Squibb Pharmaceuticals. Breyanzi is a CAR-T cell therapy, and the product was supplied direct to the trust.
NHS England commissioned the purchase. The trust awarded the £140,250 contract directly in October 2026, and no quantity or dosing schedule was published.
- What
- Medicines supply
- Value
- £140,250
- How it was bought
- Direct award
- Dates and next
- Oct 2026 to Oct 2026